DNA replication stress and cancer chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|109|2|264-271

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.2, 2018-02, pp. : 264-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

By  

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1111-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized peptide vaccination for cervical cancer patients who have received prior platinum‐based chemotherapy

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1111-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1582-1589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer immunotherapy using novel tumor‐associated antigenic peptides identified by genome‐wide cDNA microarray analyses

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 505-511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents

By  

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 902-908

John Wiley & Sons Inc

Access to resources Recommend Favorite